Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Scott

Showing results (311-320 of 360) with videos related to

Pageof 36
Sort By:
Pilot and Feasibility Studies|November 7, 2024
Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility studyAyyaz Qadir, Nabita Singh, Jenna Dean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
The Lancet. Oncology|May 31, 2024
Recent advances and impending challenges for the radiopharmaceutical sciences in oncologySuzanne E Lapi, Peter J H Scott, Andrew M Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2025
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled TrialMichelle K Yong, Karin Thursky, Megan Crane, et al.
Science Translational Medicine|October 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft modelsXin Du, Pei K Goh, Chenkai Ma, et al.
Investigational New Drugs|April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancersHui K Gan, Sagun Parakh, F T Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative ProjectCathy S Cutler, Elizabeth Bailey, Vijay Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptakeAndrew M Scott, Fook-Thean Lee, Robert Jones, et al.
Neuro-Oncology|October 28, 2017
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastomaHui K Gan, David A Reardon, Andrew B Lassman, et al.
Pageof 36

Showing results (311-320 of 360) with videos related to

Sort By:
Pageof 36
Pilot and Feasibility Studies|November 7, 2024
Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility studyAyyaz Qadir, Nabita Singh, Jenna Dean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
The Lancet. Oncology|May 31, 2024
Recent advances and impending challenges for the radiopharmaceutical sciences in oncologySuzanne E Lapi, Peter J H Scott, Andrew M Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2025
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled TrialMichelle K Yong, Karin Thursky, Megan Crane, et al.
Science Translational Medicine|October 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft modelsXin Du, Pei K Goh, Chenkai Ma, et al.
Investigational New Drugs|April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancersHui K Gan, Sagun Parakh, F T Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative ProjectCathy S Cutler, Elizabeth Bailey, Vijay Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptakeAndrew M Scott, Fook-Thean Lee, Robert Jones, et al.
Neuro-Oncology|October 28, 2017
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastomaHui K Gan, David A Reardon, Andrew B Lassman, et al.
Pageof 36